Pratik S. Multani, M.D.

Pratik S. Multani, M.D.

Chief Medical OfficeratOric Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+2% from the year before · Oric Pharmaceuticals stock +1.4% the same year

Pratik S. Multani, M.D. was paid $2.3M in FY2025 (Dec), up 2%. Oric Pharmaceuticals stock rose 1.4% that year.

Pay$100 in the stock at the end of FY21 → $36
Pay is from the Summary Compensation Table of each Oric Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Oric PharmaceuticalsPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role -41%
  2. ErascaPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Chimerix, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?